Hormone Receptor-Positive Advanced Breast Cancer: Challenges and New Treatment Options

FDA Approved AKT Inhibitor for Patients With Advanced HR-Positive Breast CancerПодробнее

HER2 Low Breast Cancer A New Therapeutic Subtype | 2023 KU Breast Cancer Year in Review ConferenceПодробнее

What's New and on the Horizon for Metastatic Breast Cancer?Подробнее

2021 West Oncology | Breast Cancer | Update on Brain MetastasesПодробнее

Metastatic Breast Cancer: Leveraging Clinical Pathways to Navigate a Complex Treatment Landscape:Подробнее

Advanced Breast Cancer: Challenges in Pathways DevelopmentПодробнее

Integrating Novel Developments for Advanced and Metastatic Breast Cancer into Improved Care PathwaysПодробнее

Optimizing Treatment Options for HER2+/ ER+ Breast Cancer using Models of Endocrine ResistanceПодробнее

Adjuvant Therapy of Breast CancerПодробнее

Advanced Hormone Receptor-positive Breast CancerПодробнее

HR+ breast cancer and visceral metastases - video abstract 72592Подробнее

Neoadjuvant Therapy for HER2-positive Breast Cancer - Dr. Scott ChristensenПодробнее